19 June 2013
Keywords: cephalon, gets, rights, gabitril, usa, acquired, expanded
Article | 14 January 2002
Cephalon of the USA has acquired expanded rights to the anti-epilepticdrug Gabitril (tiagabine) from France's Sanofi-Synthelabo and Novo
Nordisk of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 January 2002
18 June 2013
© 2013 thepharmaletter.com